Back to Search
Start Over
Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patients.
- Source :
-
British journal of cancer [Br J Cancer] 2010 Feb 16; Vol. 102 (4), pp. 731-7. Date of Electronic Publication: 2010 Jan 05. - Publication Year :
- 2010
-
Abstract
- Background: The urokinase plasminogen activator (uPA) system is one of the best-investigated protease systems, both under physiological and pathological conditions, including various types of cancer. However, effects of co-expression of members of the uPA system in soft-tissue sarcoma (STS) patients at the protein level in both tumour tissue and serum have not been investigated yet.<br />Methods: We examined 82 STS patients for protein levels of uPA, PAI-1and uPAR in tumour tissue and serum by ELISA.<br />Results: A significant correlation between high antigen levels of uPA, PAI-1 or uPAR in tumour tissue, and of uPAR in serum, with poor outcome of STS patients was found for the first time. Most strikingly, we observed an additive effect of combined uPA, PAI-1 or uPAR levels in tumour tissue extracts with uPAR levels in serum on patients' prognosis. High uPA/uPAR, PAI-1/uPAR and uPAR/uPAR antigen levels in tumour tissue/serum were associated with a 5.9-fold, 5.8-fold and 6.2-fold increased risk of tumour-related death (P=0.003, 0.001 and 0.002, respectively) compared with those patients who displayed low levels of the respective marker combination.<br />Conclusion: As expression of members of the uPA system in tumour tissue and serum is additively correlated with prognosis of STS patients, our results suggest that combinations of these biomarkers can identify STS patients with a higher risk of tumour-related death.
- Subjects :
- Adolescent
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor blood
Biomarkers, Tumor metabolism
Diagnostic Techniques and Procedures
Female
Follow-Up Studies
Humans
Male
Middle Aged
Plasminogen Activator Inhibitor 1 blood
Plasminogen Activator Inhibitor 1 metabolism
Prognosis
Receptors, Urokinase Plasminogen Activator blood
Receptors, Urokinase Plasminogen Activator metabolism
Sarcoma blood
Sarcoma metabolism
Sarcoma mortality
Survival Analysis
Urokinase-Type Plasminogen Activator blood
Urokinase-Type Plasminogen Activator metabolism
Young Adult
Plasminogen Activator Inhibitor 1 analysis
Receptors, Urokinase Plasminogen Activator analysis
Sarcoma diagnosis
Urokinase-Type Plasminogen Activator analysis
Subjects
Details
- Language :
- English
- ISSN :
- 1532-1827
- Volume :
- 102
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- British journal of cancer
- Publication Type :
- Academic Journal
- Accession number :
- 20051950
- Full Text :
- https://doi.org/10.1038/sj.bjc.6605520